The most well-characterized viral infections are those with human or economic effects. However, regardless of the organism under consideration, there are viruses able to infect that organism. Viral fossil registers highlight the long coevolutionary history between virus and host 1,2 . The outcome of such host-pathogen interactions is highly variable and ranges from deleterious infections with lethal or permanent damage to completely innocuous infections 3 . For example, acute viral infections are characterized by a high rate of viral replication and the production of a large number of progeny. Replication is transient and is limited either by death of the infected cells or by clearance of the virus by the host immune response. In contrast, persistent infections may be the result of an acute primary infection that is not cleared. In this case, the ability of the virus to be transmitted to other organisms or to the offspring of the host is maintained. Persistent infections are at the boundary that separates deleterious infections from innocuous infections. In this unique circumstance, the virus and host use attack and counterattack machinery to reach an equilibrium at which viral infection is controlled but not eliminated. Insect-virus interactions are useful models with which to delineate persistent infections, because many viruses that infect insects develop a persistent infection without obvious fitness costs to the host 4,5 . Furthermore, many persistently infected arthropods, and insects in particular, can act as vectors for emerging viral infectious diseases with considerable medical and economic effects, such as West Nile Virus or Dengue virus 6 .
A r t i c l e s
The most well-characterized viral infections are those with human or economic effects. However, regardless of the organism under consideration, there are viruses able to infect that organism. Viral fossil registers highlight the long coevolutionary history between virus and host 1, 2 . The outcome of such host-pathogen interactions is highly variable and ranges from deleterious infections with lethal or permanent damage to completely innocuous infections 3 . For example, acute viral infections are characterized by a high rate of viral replication and the production of a large number of progeny. Replication is transient and is limited either by death of the infected cells or by clearance of the virus by the host immune response. In contrast, persistent infections may be the result of an acute primary infection that is not cleared. In this case, the ability of the virus to be transmitted to other organisms or to the offspring of the host is maintained. Persistent infections are at the boundary that separates deleterious infections from innocuous infections. In this unique circumstance, the virus and host use attack and counterattack machinery to reach an equilibrium at which viral infection is controlled but not eliminated. Insect-virus interactions are useful models with which to delineate persistent infections, because many viruses that infect insects develop a persistent infection without obvious fitness costs to the host 4, 5 . Furthermore, many persistently infected arthropods, and insects in particular, can act as vectors for emerging viral infectious diseases with considerable medical and economic effects, such as West Nile Virus or Dengue virus 6 .
Flock house virus (FHV) belongs to the Nodaviridae family and is a nonenveloped virus with a bisegmented genome (RNA1, 3,107 nucleotides; RNA2, 1,400 nucleotides) of positive single-stranded RNA with a 5′ terminal methylated cap and a nonpolyadenylated 3′ end. FHV is a useful viral model because it can produce acute and persistent infections in cell culture as well as in animal models 7, 8 . Initial efforts to characterize persistent infections in vitro indicated that the FHV genome is unaltered during the establishment of persistence and that mutations of the viral genome begin to accumulate only after multiple passages on persistently infected cells 9 . Of note, mutations accumulate in RNA2, which encodes the coat protein, but not in RNA1, which encodes the viral RNA-dependent RNA polymerase and B2, a strong suppressor of RNA-mediated interference (RNAi) 10 . Those observations suggest that a change in the cellular physiology rather than the virus itself is responsible for establishing the persistent state. However, the molecular and cellular mechanisms underlying this process have remained unresolved. Other studies have associated the appearance of defective interfering particles with persistent infection by FHV 9, 11 or other RNA viruses [12] [13] [14] [15] . Defective interfering particles are unable to complete a full replication cycle because of genome deletions and consequently need wild-type viruses to replicate their genomes. Such particles can also interfere with the replication of wild-type virus through competition for viral or host factors essential for replication, facilitated by their replicative advantage due A r t i c l e s to the smaller size of their genome 16 . It has been suggested that during persistent infection of Drosophila melanogaster cells with FHV, the RNA derived from such particles is a chief contributor to the formation of virus-derived small interfering RNA (vsiRNA), because double-stranded RNA (dsRNA) from defective interfering particles could be processed more efficiently by the RNAi machinery than are viral dsRNA replicative intermediates 11, 17 . The RNAi machinery is also important in maintaining persistent infections in Drosophila cell lines 18 . That study suggests that direct 'dicing' of the viral dsRNA replicative intermediate might be one mechanism that allows control of the viral infection, as the bulk of vsiRNAs are not loaded into the RNA-silencing effector proteins argonaute 1 and argonaute 2 (Ago2). Even if the 'dicing hypothesis' was able to explain how viral replication is controlled during long-lasting infections, it does not explain how the persistent state is established, mainly because that study used cells already persistently infected with FHV.
In this work, we sought to understand how viral persistence is established and maintained in insects. We found that Drosophila cells and flies infected with FHV or other positive single-stranded RNA viruses generated DNA of viral origin through endogenous reversetranscriptase activity. We further demonstrated that those viral DNA forms were transcribed and produced vsiRNAs that 'fed' the RNAi antiviral machinery.
RESULTS

Characterization of persistently infected Drosophila S2 cells
To study how viral persistence is established and maintained in insects, we infected naive Drosophila S2 cells (S2n cells) by limiting dilution 9, 11 with several RNA viruses, including the positive singlestranded RNA viruses FHV and Drosophila C virus (DCV), and the dsRNA virus Drosophila X virus (DXV; Supplementary Fig. 1a) . Cells that survived the lytic infection proliferated and remained persistently infected even after 35 passages (Supplementary Fig. 1b) . We further characterized the S2 cell lines persistently infected with FHV (S2p cells). Immunostaining of S2p cells with antibody to FHV capsid showed that all cells were homogeneously infected by FHV (Fig. 1a) , which excluded the possibility of the presence of cells refractory to infection. Furthermore, S2p cells did not show a difference in proliferation (Fig. 1b) or death (Fig. 1c) relative to that of S2n cells, which indicated that persistent infection did not impose any fitness cost on the S2p cell population. To exclude the possibility that the selection of rare initial events contributed to the establishment of persistence independently of the virus, we tested the resistance of S2p cells to apoptosis. Both S2p and S2n cells were similarly sensitive to ultraviolet irradiation (Fig. 1d) , which indicated that the survival of S2p cells after infection was not due to a defect in apoptosis. We also tested the infectivity of the virus produced by S2p cells. Wild-type (w 1118 ) flies infected with 500 TCID 50 (half-maximal tissue culture infectious dose) of virus recovered from the supernatants of either S2p cells or acutely infected S2n cells died at a similar rate (Fig. 1e) , which indicated that persistence was not established from a less-virulent virus population or from a loss of virulence during infection. As neither cell fitness nor FHV virulence was altered in S2p cells, we next hypothesized that the persistence could have resulted from the control of viral replication below a cytopathogenic threshold that would be accompanied by less production of virus in S2p cells 11 . We compared viral titers after acute and persistent infection and observed that viral titers were significantly lower in S2p cells (Fig. 1f) ; accordingly, there was also less accumulation of viral RNA segments during persistent infection (Supplementary Fig. 1c) . As viral titers varied in S2n cells versus S2p cells, we analyzed differences in the antiviral response. In insects, the main antiviral response acts through the canonical Dicer-2 (endoribonuclease)-Ago2 siRNA pathway 10, [19] [20] [21] . To assess the antiviral RNAi response in S2p and acutely infected S2n cells, we produced small-RNA libraries and examined the vsiRNA profiles. We found vsiRNAs that mapped all along both FHV genome segments (RNA1 and RNA2; Supplementary Fig. 1d-g ), which indicated that the RNAi machinery effectively processed the viral dsRNA in both conditions. Together these observations showed that persistently infected cells produced less virus because of control of viral replication by an unknown cellular mechanism.
New cellular synthesis of viral cDNA from viral RNA RNA from non-retroviral RNA viruses can be reverse-transcribed into cDNA by retrotransposons or endogenous retroviruses [22] [23] [24] [25] [26] [27] [28] [29] [30] . The role of non-retroviral DNA forms of RNA viruses remains unresolved, although involvement in immunity has been proposed 25, 26 . Hence, we investigated whether RNA viruses generated DNA forms in Drosophila cells and whether those DNA forms correlated with the establishment and maintenance of persistent infection. We extracted genomic DNA 
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A r t i c l e s from S2 cell lines persistently infected with FHV, DCV or DXV and amplified the DNA with primers complementary to various regions of the viral genomes. All samples contained DNA sequences ( Fig. 2a and Supplementary Fig. 2a,b) , a result we further confirmed by sequencing. Sindbis virus, an arbovirus that naturally produces persistent infection in insects, also produced a DNA form ( Supplementary  Fig. 2c ). When we treated DNA samples with RNase III, a mixture of RNase A and RNAse I, DNase I or exonuclease I, only DNase I precluded the generation of a PCR product ( Supplementary  Fig. 2d and data not shown), which confirmed that the molecular template was a DNA molecule. Through the use of 'genome walking' , we extended the initially identified sequences corresponding to FHV RNA1 and reconstructed the FHV DNA forms present in S2p cell lines ( Fig. 2a and Supplementary  Fig. 3a) . The DNA form was heavily reorganized, with a major recombinant RNA1 segment considerably shorter than the usual 3,107 nucleotides ( Supplementary Fig. 3a,b) . Nonhomologous RNA recombination during negative-strand synthesis of FHV RNA1 and RNA2 could have been the template for those new DNA structures 31 . Alternatively, defective interfering particles could have served as a template 32, 33 , as the DNA forms had breakpoints and rearrangements similar to those identified in RNA1 defective interfering particles 11 . Of note, we also identified DNA forms derived from FHV RNA2 that were similar in sequence to RNA2 defective interfering particles 11, 32 (data not shown). We then infected S2n cells with FHV at a multiplicity of infection (MOI) of 0.5 and monitored the appearance of FHV DNA over time by PCR. DNA forms were detectable as early as 12 h after infection (Fig. 2b) .
Because reverse transcriptases encoded by retrotransposons and endogenous retroviruses are widespread in insect genomes 34, 35 , we determined if we could detect reverse-transcriptase activity in S2 cells. We detected robust Mn 2+ -dependent reverse-transcriptase activity in extracts of S2n cells (Fig. 2c) . Additionally, we found that such activity was sensitive in vitro to the nucleoside reverse-transcriptase inhibitor azidothymidine (AZT) triphosphate to a degree similar to that achieved for a recombinant retroviral reverse transcriptase (Fig. 2d) . Next we determined whether treating S2n cells with AZT would inhibit the appearance of FHV DNA after infection with FHV. Indeed, AZT triggered a dose-dependent inhibition of FHV DNA in S2n cells infected with FHV at an MOI of 0.5 ( Fig. 2e) . We confirmed that AZT did not impair the growth of S2 cells at the concentrations and time used (Supplementary Fig. 4a ). Moreover, AZT did not inhibit FHV replication in persistently infected cells in which the DNA form was already present (S2p cells; Supplementary Fig. 4b,c) . Therefore, AZT seemed to be specifically blocking the generation of viral DNA rather than affecting the viability of the cell or virus.
As mitochondrial dysfunction is a known potential side effect of AZT, and as FHV replicates on the mitochondrial external membrane, we also tested the effect of AZT treatment on other viruses, such as DCV and Sindbis virus, whose replication is not associated with mitochondria. In S2 cells, 5 mM AZT also inhibited the synthesis of a viral DNA form after infection with DCV or Sindbis virus at an MOI of 0.5 ( Fig. 2f,g ). Finally to rule out the possibility of any effects specific to S2 cells, we also analyzed the generation of FHV DNA forms and its inhibition by treatment with AZT in another Drosophila cell line, Kc167. The appearance of FHV DNA after infection of those cells (Fig. 2h ) indicated that our results were not unique to S2 cells but were instead a general characteristic of insect cells. Thus, during the establishment of viral persistence, RNA viruses and/or their defective interfering particles were reverse-transcribed into viral DNA forms Fig. 4d ), the accumulation of vsiRNA was considerably impaired in cells treated with AZT and thus in the absence of FHV DNA forms ( Fig. 3a and Supplementary Fig. 4e ). In contrast, the global amount of miRNA remained unchanged despite treatment with AZT ( Fig. 3a) , which indicated that at the doses and time used, AZT did not have pleiotropic effects. We then characterized the sequence diversity of vsiRNA 'reads' . Cells with the DNA form had vsiRNAs that mapped to the junctions of the DNA-form rearrangements, whereas those vsiRNAs were undetectable in cells treated with AZT ( Table 1) . Those results suggested that the FHV DNA form was transcribed and processed into specific vsiRNAs. To determine whether inhibition of the synthesis of FHV DNA and the associated lower amount and diversity of vsiRNAS affected the ability of S2 cells to control FHV replication, we measured viral loads after prolonged exposure to AZT. When the DNA form was inhibited, the viral load was up to 1,000-fold higher than that of infected cells in which the DNA form was present (Fig. 3b) . That higher viral titer when the appearance of FHV DNA was prevented was accompanied by more cell death (Fig. 3c) , which indicated that the DNA form was needed to establish persistence. Together these observations emphasized the requirement for the viral DNA form at early time points during infection to improve the antiviral response and to allow the establishment of persistence.
Retrotransposons provide reverse-transcriptase activity Having linked the appearance of FHV DNA forms to the establishment of persistent infection, we next defined the mechanism by which protection was conferred. We hypothesized that determining the structure and the genomic location of FHV DNA would suggest a mode of action. We thus analyzed the genome of S2p cells by deep sequencing. Analysis of chimeric paired-end 'reads' showed that most viral DNA forms (nine of ten) were fused to fragments corresponding to long-terminal repeat (LTR) retrotransposons, mainly 297, blood, diver, micropia and invader2 elements ( Fig. 4a and Supplementary Table 1 ). That result suggests that FHV RNA was reverse-transcribed by the reverse-transcriptase activity of a broad set of retrotransposons actively transcribed in S2 cells (Supplementary Fig. 5a ). In some paired-end 'reads' , we were able to identify the exact crossover point between micropia and FHV DNA ( Fig. 4b and Supplementary  Fig. 5b,c) . That junction was one nucleotide distant from the end of the LTR of micropia, which would suggest a possible 'forced copy-choice' recombination mechanism, as has been proposed for the recombination between retrotransposons and lymphocytic choriomeningitis virus in mice 24 . Because of the repetitive and polymorphic nature of the retrotransposon sequences, we were unable to unambiguously assign chromosomal positions to those FHV DNA forms. Alternatively, the DNA-repair machinery can also process nuclear retroviral DNA to produce stable extrachromosomal circular molecules with a single LTR or two LTRs 36 ; thus, we cannot exclude the possibility that the viral DNA form was located on such extrachromosomal molecules. In summary, these results indicated that LTR retrotransposons were the likely source of the reverse-transcriptase activity that produced FHV DNA fragments that were embedded in LTR retrotransposon DNA.
Production of vsiRNAs from newly synthesized viral cDNA
The presence of chimeric DNA molecules consisting of viral cDNA and retrotransposon DNA is not sufficient by itself to explain the mechanism by which persistence is reached. We thus hypothesized that a transcript from the FHV-retrotransposon DNA chimera might produce small RNAs that mediate protection against acute infection through the RNAi machinery, as suggested by the greater number and diversity of vsiRNAs observed (Fig. 3a,b) . To assess the involvement of RNAi in this process, we depleted S2p cells of Dicer-2 (a core component of RNAi) 18 or CG4572 (an uptake-spread component of RNAi) 37 by knockdown via RNAi and measured cell death. The equilibrium 
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A r t i c l e s between viral replication and persistence was broken in cells in which those genes were silenced by RNAi, which shifted the persistent infection to an acute infection that induced cell death (Fig. 4c) . To further confirm the involvement of the RNAi response, we generated small-RNA libraries from S2p cell lines. As each vsiRNA could originate from either replicating viral dsRNA (profiles, Supplementary  Fig. 1d-g ) or virus-retrotransposon chimeric transcripts, the only way to discriminate small RNAs specifically from the transcription of the DNA form was to identify those small RNAs whose sequence mapped partly to the virus and partly to the Drosophila genome. We expected these chimeric virus-Drosophila small RNAs to be very infrequent. To improve detection, we treated the samples to β-elimination (which prevents ligation on the 3′ end of the RNA unless it bears a 3′ modification) to discriminate small RNAs loaded into Ago2 complexes and bearing a 3′ 2′-O-methyl from the total small-RNA background. The frequency at which such virus-Drosophila small-RNA chimeras occurred ranged from 1.15 to 2.3 per 10,000 total unique sequences (Fig. 4d) . Indeed, in S2p cells, we unambiguously identified over 899 chimeric small RNAs that were loaded into Ago2 (241 and 427 for S2p 1 cell lines a and b, respectively, and 231 for the S2p 2 cell line) when we aligned small-RNA libraries with the FHV and Drosophila genome reference sequences. We further confirmed the existence of those chimeric small RNAs by analyzing publicly available small-RNA libraries generated from persistently infected S2 cells in other laboratories (Supplementary Fig. 6 ). Of note, in the libraries analyzed, all the chimeric 'reads' mapped to retrotransposons on their Drosophila part, and ~65% of their virus-derived sequences matched the positive strand of FHV. Thus, the presence of chimeric small RNAs that mapped partly to Drosophila retrotransposons and partly to FHV further confirmed that the RNA was transcribed from FHV DNA templates and was processed by the siRNA machinery into vsiRNA.
Inhibiting the viral DNA form increases the viral load in vivo
To determine if mechanisms similar to those described above could be involved in viral persistence in vivo, we infected wild-type flies with 20 TCID 50 FHV and monitored the appearance of the FHV DNA form over time by PCR of single flies. We detected fragments of FHV DNA in vivo from day 4 onward (Fig. 5a) . Characterization of the FHV RNA1 sequence of those DNA forms identified an almost complete full-length DNA as well as reorganized forms similar to those present in S2p cells (Supplementary Fig. 3c ). The appearance of a DNA form in infected flies was a common event, with 84.7% of 200 FHV-infected flies having a DNA form and 58% of 200 Sindbis virus-infected flies having a DNA form at day 6 after injection.
To assess the effect of the DNA form on the antiviral response in vivo, we developed a protocol for natural inoculation with FHV by feeding. We maintained flies in the presence of 25% sucrose and 93 mM AZT from day 2 after eclosion. At day 4 after eclosion, we fed the flies overnight pure FHV stock (1 × 10 9 TCID 50 per ml), then monitored survival every day for 16 d. After that natural infection protocol, we found that flies infected with FHV but not treated with AZT controlled viral infection (Fig. 5b) and had a death rate undistinguishable from that of uninfected flies (Fig. 5c) . In contrast, when treated with AZT, infected flies were unable to contain viral replication, as shown by their high viral titers at day 13 (Fig. 5b) , and >75% of the flies died within 13 d of infection (Fig. 5c) . In control experiments, uninfected flies treated with AZT had a low death rate over the course of the experiment, which excluded the possibility of considerable pleiotropic effects of AZT alone (Fig. 5c) . Of note, we originally developed a double-injection protocol in which we injected flies daily intrathoracically with AZT and challenged them with FHV. This protocol proved to be lethal for the flies beyond 6 d because of repeated physical injury; however, when analyzed, this injection protocol yielded a similar result: in the absence of a DNA form, infected flies died because of an increase in viral replication (data not shown). Collectively, these results confirmed that inhibition of FHV DNA synthesis affected the establishment of persistent infection and demonstrated a role for the DNA form in antiviral immunity in vivo. Together our data demonstrated that RNAi and retrotransposons acted together to establish and maintain persistent viral infection in insects; these results provide a mechanistic framework for understanding this process (Fig. 6) .
DISCUSSION
The host-pathogen interaction triggers selection pressures on both organisms that drive the development of survival strategies. This survival sometimes indicates the incorporation or endogenization of the full parasitic organism by the host, as noted for the endosymbiont bacterium Wolbachia, which protects fruit flies and mosquitoes against infection with various viruses 38, 39 . In other cases, only part of the parasitic genome is endogenized 26 ; for example, bees whose genomes have integrated fragments of Israeli acute paralysis virus are resistant to further challenge with that virus 26 . Our results have demonstrated that one possible root of viral persistence, commonly observed in insects and other arthropods 40 , is the endogenization of viral RNA sequences. Indeed, the establishment of persistent viral infection depends on the formation of viral cDNA fragments from which small RNAs are produced by the RNAi machinery. We postulate that viral dsRNA, the canonical substrate of the antiviral RNAi machinery, is also generated from viral cDNA. The biogenesis of that dsRNA remains unknown and should be the subject of future research. However, we speculate that dsRNA might originate from a singlestranded viral transcript generated from the DNA form annealed to the viral genome (either the positive or negative strand, depending on the orientation of the transcript). Another possibility is that a singlestranded viral transcript generated from the DNA form folds back on itself and forms double-stranded secondary structures that could be recognized by Dicer and could enter the RNAi pathway, similar to endogenous siRNA. A third possibility is two complementary single-stranded viral transcripts generated from different loci or by convergent transcription. When the DNA form is inhibited, dsRNA produced through one or several of these mechanisms 3 disappears, with a consequent decrease in vsiRNA.
Given our data, we propose the following model to explain the establishment and maintenance of persistent infection with RNA viruses in insects. After viral infection, ongoing viral replication is limited either by the death of the infected cell or by the antiviral RNAi response in the host. During that process, viral RNA is reversetranscribed by endogenous reverse-transcriptase activity of LTR retrotransposons. The resulting DNA molecule can then be imported in the nucleus, where retrotransposon-mediated integration into the host genome takes place 34 . Alternatively, the DNA-repair machinery can produce stable extrachromosomal circular DNA molecules that are efficiently transcribed 36 . In all cases, the viral DNA is continuously transcribed and produces dsRNA, which is recognized and processed by the RNAi machinery that boosts the antiviral response. . Those viral forms are reverse-transcribed by cellular reverse-transcriptase activity into DNA forms (green) that may integrate into the host genome or be processed into extrachromosomal circular DNA. The sequences of viral origin, now in DNA form, will produce transcripts (black) that form dsRNA that is recognized by Dicer-2 and is further processed by a small RNA-related pathway. When viral small RNA from those transcripts reaches the RNA-induced silencing complex (RISC), the ongoing infection is contained and the acute infection is controlled. In this way, both cell and virus progress into a metastable equilibrium that defines the state of persistent infection.
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It is possible that such dsRNA molecules are more exposed to Dicer-2 than are viral replication intermediates, and then the resulting small RNAs are loaded into the RNA-induced silencing complex. When a small RNA that is transcribed and processed from a viral DNA form reaches that complex, the ongoing infection can be better contained and controlled, as the immune response is already primed. In this way, both cell and virus have time to reach a metastable equilibrium (persistent infection).
In the model proposed, the interactions between two parasites (transposon and virus) and the RNAi pathways that control them determine the outcome of the infection. In our model, the basal protection afforded by RNAi during viral infection and the priming of the RNAi response in uninfected cells 37 are key to providing the time the cell needs to initiate the persistence mechanism and to control viral infection. In this way, the virus-transposon interaction serves an important role in the modulation of the immune system: the characteristically massive production of virus followed by cell death in acute infection is compromised, yet viral dissemination in the persistent state is still ensured. We also speculate that in the absence of the canonical production of secondary small RNAs by RNA-dependent RNA polymerase in insects, this mechanism of transformation of viral RNA into DNA, then into RNA and finally into small RNA could be amplifying and maintaining the antiviral immune response throughout the insect's life after primary exposure. By the mechanism proposed, the RNAi immune response is triggered by viral dsRNA replication intermediates and is amplified and boosted through newly generated viral cDNA-derived dsRNA molecules. As defective interfering particles could be the template for new viral DNA synthesis, a similarity to interferon activation in mammalian cells can be seen. Indeed, viruses such as paramyxoviruses can activate the interferon cascade independently of viral protein synthesis but by a mechanism dependent on defective interfering particles 41 . In this model, the integrity of the defective interfering particle genomic RNA seems to be required for efficient interferon induction. In insects, the considerable sequence similarity among FHV DNA forms and defective interfering particles in different S2p cell lines in vitro, as well as in vivo, suggests a link between defective interfering particles and the biogenesis of viral DNA. Our results are compatible with two possibilities. In one, defective interfering particle RNAs are used as a template by retrotransposon reverse transcriptases to generate viral DNA forms. In the other, viral DNA is the template for the production of defective interfering particles. Further studies addressing this issue could connect defective interfering particles to persistent infections and explain how these are linked.
Until now, endogenization of DNA has been considered a rare event, as it has been assumed that only endogenization in the germline has an effect on host evolution. However, somatic (or 'nontransmissible') endogenization may be much more frequent than expected, as the restrictions on genome integrity in the soma could be more relaxed. DNA forms of nonretroviral viruses have been described in a wide variety of eukaryotic organisms, from plants to mammals 24, 25, [27] [28] [29] [30] . Whether those DNA forms are also involved in immunity mediated by small RNA or other types of immune responses in other organisms is an open question that deserves further exploration. The model proposed here offers a new perspective on antiviral immunity that considers persistent infection the result of the concerted effort of the host's multiple defense pathways.
METHODS
Methods and any associated references are available in the online version of the paper. 
ONLINE METHODS
Cells and cell assays. Drosophila S2 cells (Invitrogen) and Kc167 cells were cultured at 25 °C in Schneider's Drosophila medium supplemented with 10% heat-inactivated FCS. For cell-proliferation assays, S2 cells were incubated for 15 min at room temperature in the presence of 2 µM CFDA (5-(and 6-) carboxyfluorescein diacetate; Invitrogen) and were washed twice with PBS. For cell-viability assays, 1 µg/ml of propidium iodide was added to the cells, followed by incubation for 5 min at room temperature. Cellular fluorescence of 5 × 10 4 cells was analyzed at various times after staining with a FACSCalibur and CellQuest software. Alternatively (for Fig. 3d) , for quantification of the viability of FHV-infected S2 cells in presence or absence of AZT, a portion of the infected cells was removed and stained for 5 min with 0.2% trypan blue (Sigma-Aldrich). For ultraviolet irradiation-induced DNA damage, cells were exposed to increasing doses of ultraviolet irradiation. At 72 h after irradiation, cell viability was measured by CellTiter-Glo Luminescent Cell Viability Assay (Promega).
Viruses. FHV, DCV and DXV viral stocks were prepared on low-passage S2 cells and titers were measured by end-point dilution. S2 cells (25 × 10 4 cells per well in a 96-well plates) were inoculated with tenfold dilutions of virus stocks. At 7 or 14 d after infection, cytopathic effects were analyzed. Viral titers were calculated as TCID 50 (half-maximal tissue culture infectious dose) according to a published method 42 .
For quantification of viral titers in flies, five flies were homogenized at various time in 250 µL PBS, and titers in the homogenate were calculated as described above.
Sindbis viral stock was prepared in BHK hamster kidney cells and titers were measured by plaque assay.
Fly infection. For infection of flies by injection, w 1118 flies were used as wildtype controls; these were reared on standard medium at 25 °C. Four-day-old female flies were injected intrathoracically with 50 nl of a FHV dilution in 10 mM Tris-HCl (pH 7.5) as described 43 , with a Nanoject II injector. For analysis of survival, FHV was injected at a dose of 500 TCID 50 per fly. Mockinfected flies were injected with 10 mM Tris-HCl, pH 7.5. Fly mortality at day 1 was attributed to damage produced by the injection procedure and those data were excluded from further analysis. Mortality was monitored daily for 14 For infection of flies by viral feeding, the following procedure was used for the AZT in vivo assay: w 1118 flies were fed 93 mM AZT in 25% sucrose daily from day 2 after eclosion or were not fed AZT. At day 4 after eclosion, flies were fed a pure stock of FHV (1 × 10 9 TCID 50 per ml) or Tris-HCl 10 mM, pH 7.5 (as a control), once overnight. Survival was monitored every day for 16 d. Flies were kept at 25 °C. At various time points, flies were collected and viral titers were calculated as described above.
For single-fly PCR, each fly was homogenized in 50 µl squishing buffer (100 mM Tris-HCl, 25 mM NaCl, 1 mM EDTA, pH 8, and 0.2 mg/ml proteinase K) and incubated for 1 h at 37 °C. Proteinase K was inactivated for 2 min at 95 °C. A portion of the homogenate (1 µl) was treated for 30 min at 37 °C with 10 units of DNase I (Roche) or not, followed by heat inactivation (72 °C for 10 min). A portion of the sample (1 µl, corresponding to 0.1 µl of the original homogenate) was analyzed by PCR.
two Blastall series (versus FHV and versus Drosophila), with selection of only the unique sequence with at least 1 'hit' against FHV and 1 'hit' against Drosophila and whose positions were considered nonoverlapping. Results that allowed 0, 1 and 2 overlapping bases between the two hits were examined for all the unique sequences. Only unique sequences representing at least five 'reads' on the original small-RNA library were retained. This second step was specifically designed to 'fish out' chimeric transcripts with high confidence.
Of note, to detect chimeric small RNAs that unambiguously map partly to Drosophila and partly to FHV, we applied very stringent mapping and filtering parameters. By doing this, we may have lost many chimeric 'reads' that were unable to pass the filters, and thus the final numbers are low (Fig. 4d  and Supplementary Fig. 6 ).
For comparison of small-RNA libraries with or without AZT treatment, the following procedures were used. For miRNA analysis, the mirBase database was used as reference. Mapping was done with Bowtie software, with applying a seed of 21 nts with a maximum of 2 mismatches. Each miRNA was quantified in the presence or absence of AZT with SAMtools. FHV small RNAs were mapped with Bowtie software for the alignment of short DNA sequences, and a maximum of two mismatches was allowed. The mapping of siRNAs was annotated for each position of FHV RNA1.
Silencing assay. S2 cells (~1 × 10 6 ) were transfected with dsRNA with Effectene (QIAGEN). The dsRNA was generated by in vitro transcription from T7 promoter-flanked PCR products, with. 2 µg dsRNA used per condition in six-well plates with a 2 ml final volume of Schneider's medium. After 3 d of dsRNA treatment, cells stained with propidium iodide, followed by analysis with a FACSCalibur and CellQuest Software.
RNA blot analysis. Total RNA was isolated with TRIzol (Invitrogen). RNA (24 µg) was separated by electrophoresis through 1.5% denaturing agarose gels, then transferred to a Nytran SuperCharge membrane with the Turbo Blotter system (Whatman). RNA was crosslinked to membranes by ultraviolet irradiation (Stratalinker) and was prehybridized for 2 h at 39 °C in ULTRAhyboligo buffer (Ambion) . DNA oligonucleotide probes with complementary to FHV RNA1 and RNA3 and to FHV RNA2 were end-labeled with 32 P with T4 polynucleotide kinase (Fermentas), then were added to the hybridization buffer, followed by incubation overnight at 39 °C. Membranes were washed several times at 39 °C in 0.1× saline-sodium citrate with 0.1% SDS and then exposed to a PhosphoImager screen. Probes were stripped by boiling of the membrane twice in 0.1% SDS for a second round hybridization with Rp49 as a 'housekeeping' control.
Quantitative real-time RT-PCR. Total RNA was extracted from S2 cells with TRIzol (invitrogen), then 1 µg total RNA was treated with DNase I according to the manufacturer's instructions (Roche). The cDNA was prepared by reverse transcription with iScript Reverse Transcriptase (BioRad) with oligodT and random hexamer primers. Roche Universal Sybr Green Master Mix (Rox) and a StepOne Plus (Applied Biosystems) were used for quantitative RT-PCR. The change-in-threshold values were calculated within the log-linear phase of the amplification curve with the StepOne Plus V2.2.2 software (Applied Biosystems). Quantification was normalized to that of mRNA encoding the endogenous ribosomal protein Rp49. Oligonucleotide primers were as follows:
DNA oligonucleotides (5′ to 3′): RNA blot: Gal80-F TAATACGACTCACTATAGGGAGAGGGCCCTTGCATGT  TCACTAG  T7Gal80-R TAATACGACTCACTATAGGGAGACCTTTGAAACTGCAT  GACACTGG  T7 CG4572-F TAATACGACTCACTATAGGGAGACTATAGTCGCAAT  AAGCGGAGC  T7 CG4572-R TAATACGACTCACTATAGGGAGATATGGCATTTTGT  ACCTTGTGG  T7 Dcr2-F TAATACGACTCACTATAGGGAGAAAGCGGTTGTAGTTG  ATATCGC  T7 Dcr2-R TAATACGACTCACTATAGGGAGAAGTACGTATCCCGTA  GAGCTGG  Quantitative RT-PCR: 297-F TGGACGGACAAATTACACGA 297-R TCCGATTGGTTACCTTCCAG blood-F GACCAAAGCCCTTGACCATA blood-R TACTTCGCACCACGAAGTTG micropia-F ATATTGTTCGCCCAAGTTGC micropia-R TAATTTGCTCCGCGAAGTCT copia-F GGAGGTTGTGCCTCCACTTA copia-R CTCTTGGAGACGCTTTACGG mdg1-F AAGCCTGCCTGTTTTCAAGA mdg1-R TGCTTCACTCTGACCCTCCT gapdh-F TGATGAAATTAAGGCCAAGGTTCAGGA gapdh-R TCGTTGTCGTACCAAGAGATCAGCTTC rp49-F ATCGGTTACGGATCGAACA rp49-R ACAATCTCCTTGCGCTTCTT FHV1-F CCAGATCACCCGAACTGAAT FHV1-R AGGCTGTCAAGCGGATAGAA
